Approved for Long-term maintenance treatment of airflow obstruction in patients with COPD. Combines tiotropium (LAMA) and olodaterol (LABA) in a soft mist inhaler. Dual mechanism blocks muscarinic bronchoconstriction while stimulating beta-2 mediated bronchodilation. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC…
Loading full data from Know Your Drugs Institute…